Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

NCT05584722 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05584722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05584722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2022
Completion date
August 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy individuals with no cardiopulmonary disease, heritable pulmonary arterial hypertension, idiopathic pulmonary arterial hypertension, unaffected mutation carriers: healthy participants with a known bmpr2 gene mutation and normal pulmonary pressure and rv function on echo